mr. bernard, we want you to explain to the american people why bristol myers squibb charges patients in our country $700 a year for eloquence, when that same exact product can be purchased for just $900 in canada, $650 in france. mr. duato, , where going to ask you why johnson & johnson charges americans with arthritis $79,000 for stone barrel when that same example can be purchased for just 20,000 in canada and just 12,000 in france. mr. davis, please tell us later why merck charges americans with cancer $191,000 a year for keytruda in the same product can be purchased for 112,000 in canada and $91,000 in france. let's be clear, johnson & johnson, merck and bristol myers squibb are not just charging higher prices in the united states compared to other countries. they are also charging americans much higher prices today than they did in the past, even accounting for inflation. from 2004-282 the eighth the median price of new innovative drugs sold by these three copies was just $14,000. in